| Description | CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay). |
| Target activity | CCR1:1.8 nM （in Ca2+ flux assay) |
| molecular weight | 451.47 |
| Molecular formula | C22H18FN5O3S |
| CAS | 1295298-26-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Harcken C, et al. Identification of novel azaindazole CCR1 antagonist clinical candidates. Bioorg Med Chem Lett. 2019 Feb 1;29(3):441-448. |